title: Comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'.
authors.affiliation: Department of Gastroenterology, Poitiers University Hospital, Poitiers, France.
authors.forename: D
authors.initials: D
authors.lastname: Tougeron
authors.affiliation: UMR-S775, INSERM, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Laurent-Puig
authors.affiliation: 1] UMR-S775, INSERM, Paris, France [2] Department of Gastroenterology and Digestive Oncology, European Georges Pompidou University Hospital, AP-HP, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Zaanan
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000097:blood* / Q000188:drug therapy*; D004273:DNA, Neoplasm / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D011518:Proto-Oncogene Proteins / Q000097:blood* / Q000235:genetics*; D018631:ras Proteins / Q000097:blood* / Q000235:genetics*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D004273:DNA, Neoplasm; D011518:Proto-Oncogene Proteins; D018631:ras Proteins; D002166:Camptothecin